Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis.
Michele FornaroClaudio CaiazzaMartina BilleciMichael BerkWolfgang MarxVicent Balanzá-MartínezMichele De PriscoRosanna PezoneGiuseppe De SimoneNiccolo' SoliniFelice IasevoliFabrice BernaGuillaume FondLaurent BoyerAndre Fèrrer CarvalhoElena DragiotiJess G FiedorowiczAndrea de BartolomeisChristoph U CorrellMarco SolmiPublished in: Research square (2024)
Sarcosine, citicoline, and N-acetylcysteine are promising augmentation interventions in stable patients with schizophrenia, yet the quality of evidence is low to very low. Further high-quality trials in acute phases/specific outcomes/difficult-to-treat schizophrenia are warranted.